Accelerate Diagnostics, Inc

UBS Group AG

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

50,811

Value ($000)

41

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	41	0.0%	50,811	6/30/2023
2023 Q1	5/12/2023	36	0.0%	50,800	3/31/2023
2022 Q4	2/8/2023	1	0.0%	800	12/31/2022
2022 Q3	11/10/2022	13	0.0%	8,813	9/30/2022
2022 Q2	8/10/2022	44	0.0%	43,593	6/30/2022
2022 Q1	5/16/2022	6	0.0%	3,948	3/31/2022
2021 Q4	2/14/2022	74	0.0%	14,232	12/31/2021
2021 Q3	11/15/2021	14	0.0%	2,495	9/30/2021
2021 Q2	8/13/2021	51	0.0%	6,342	6/30/2021
2021 Q1	5/12/2021	148	0.0%	17,817	3/31/2021
2020 Q4	2/11/2021	133	0.0%	17,494	12/31/2020
2020 Q3	11/12/2020	94	0.0%	8,808	9/30/2020
2020 Q2	7/31/2020	1,292	0.0%	85,213	6/30/2020
2020 Q1	5/1/2020	1,678	0.0%	201,414	3/31/2020
2019 Q4	2/14/2020	3,505	0.0%	207,367	12/31/2019